---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-063491"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:37:59.388975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HeartSciences expands equity plan to 1M shares, grants RSUs and options tied to FDA clearance

## Summary
- Board approved amendment to 2023 Equity Incentive Plan increasing maximum shares to 1,000,000; subject to shareholder vote at next annual meeting.
- CEO Andrew Simpson received 68,750 RSUs; COO Mark Hilz received 56,250 RSUs; vest upon FDA clearance of MyoVista Device or Change of Control.
- Granted options: CEO 275,000, COO 225,000, CFO 25,000 at $4.37/share, vesting over three years with acceleration on FDA clearance.
- Non-employee directors each received 25,000 options at $4.37.
- As of July 11, 2025, raised $1.7M from Reg A offering (487,701 units) and exchanged $855K debt for 233,229 shares; total shares outstanding ~1.555M.

## SEC filing metadata
- accession: 0001213900-25-063491
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390025063491/0001213900-25-063491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390025063491/ea0248765-8k_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-063491
- JSON: https://secwatch.observer/filing/0001213900-25-063491.json
- Plain text: https://secwatch.observer/filing/0001213900-25-063491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.